Forskolin Pharma Private Limited, a active private limited company, was established on 23 October 2018 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909KA2018PTC117863. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Seshadri Srinivasan (Director), Madenuru Govindaraj Sreelatha (Director), Gangadhar Mallappa (Additional Director). It holds ₹5.80 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 26/1 Dr.D V G Road Basavanagudi, Bengaluru, Karnataka, 560004.
U46497KA2018PTC117863
117863
23 October 2018
₹1.00 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Forskolin Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Seshadri Srinivasan | Director | 23 Oct 2018 | Current |
| Madenuru Govindaraj Sreelatha | Director | 23 Oct 2018 | Current |
| Gangadhar Mallappa | Additional Director | 22 Jun 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Forskolin Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.43% decrease. The company also saw a substantial improvement in profitability, with a 109.64% increase in profit. The company's net worth Soared by an impressive increase of 92.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Forskolin Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2020 | Axis Bank Limited | ₹5.80 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Forskolin Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Forskolin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Forskolin Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Forskolin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Forskolin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Progress on Gangadhar Mallappa was appointed as a Additional Director was appointed as a Additional Director on 22 Jun 2021 & has been associated with this company since 4 years 5 months . was documented.
Progress on A charge with Axis Bank Limited amounted to Rs. 5.80 M with Charge ID 100385716 was registered on 29 Oct 2020. was documented.
Progress on Seshadri Srinivasan was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 7 years 1 month . was documented.
Progress on Madenuru Govindaraj Sreelatha was appointed as a Director was appointed as a Director on 23 Oct 2018 & has been associated with this company since 7 years 1 month . was documented.
The CIN of Forskolin Pharma Private Limited is U46497KA2018PTC117863.
Forskolin Pharma Private Limited is headquartered at No. 26/1 Dr.D V G Road Basavanagudi, Bengaluru, Karnataka, 560004.
Forskolin Pharma Private Limited was incorporated on 23 October 2018.
The current directors of Forskolin Pharma Private Limited are
The primary industry of Forskolin Pharma Private Limited is Trade.
Forskolin Pharma Private Limited is unlisted.
The authorized capital of Forskolin Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX